BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27091136)

  • 1. Early-phase wound healing and long-term outcomes of a selective endovascular-first approach for treating Rutherford 5 critical limb ischemia with infrainguinal lesions.
    Inoue K; Onohara T; Mikasa K; Furuyama T
    Surg Today; 2016 Nov; 46(11):1301-9. PubMed ID: 27091136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open Versus Endovascular Revascularization of Below-Knee Arteries in Patients With End-Stage Renal Disease and Critical Limb Ischemia.
    Meyer A; Schilling A; Kott M; Rother U; Lang W; Regus S
    Vasc Endovascular Surg; 2018 Nov; 52(8):613-620. PubMed ID: 30021493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endovascular treatment for infrainguinal vessels in patients with critical limb ischemia: OLIVE registry, a prospective, multicenter study in Japan with 12-month follow-up.
    Iida O; Nakamura M; Yamauchi Y; Kawasaki D; Yokoi Y; Yokoi H; Soga Y; Zen K; Hirano K; Suematsu N; Inoue N; Suzuki K; Shintani Y; Miyashita Y; Urasawa K; Kitano I; Yamaoka T; Murakami T; Uesugi M; Tsuchiya T; Shinke T; Oba Y; Ohura N; Hamasaki T; Nanto S;
    Circ Cardiovasc Interv; 2013 Feb; 6(1):68-76. PubMed ID: 23362307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of statin treatment after endovascular therapy for isolated below-the-knee disease in patients with critical limb ischemia.
    Tomoi Y; Soga Y; Iida O; Hirano K; Suzuki K; Kawasaki D; Yamauchi Y; Miyashita Y; Tazaki J; Nobuyoshi M
    Cardiovasc Interv Ther; 2013 Oct; 28(4):374-82. PubMed ID: 23756936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infra-inguinal bypass surgery vs endovascular revascularization for chronic limb-threatening ischemia in average- and high-risk patients.
    Morisaki K; Matsuda D; Guntani A; Kinoshita G; Yoshino S; Inoue K; Honma K; Yamaoka T; Mii S; Yoshizumi T
    J Vasc Surg; 2024 Jul; 80(1):204-212.e3. PubMed ID: 38522583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Effects of Planned Endovascular Therapy for Critical Limb Ischemia Patients with Tissue Loss.
    Fukunaga M; Kawasaki D; Nishimura M; Yamagami M; Fujiwara R; Nakata T
    J Atheroscler Thromb; 2019 Mar; 26(3):294-301. PubMed ID: 30135330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of delayed wound healing after endovascular therapy of isolated infrapopliteal lesions underlying critical limb ischemia in patients with high prevalence of diabetes mellitus and hemodialysis.
    Shiraki T; Iida O; Takahara M; Soga Y; Yamauchi Y; Hirano K; Kawasaki D; Fujihara M; Utsunomiya M; Tazaki J; Yamaoka T; Shintani Y; Suematsu N; Suzuki K; Miyashita Y; Tsuchiya T; Uematsu M
    Eur J Vasc Endovasc Surg; 2015 May; 49(5):565-73. PubMed ID: 25747344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wound Blush Obtainment Is the Most Important Angiographic Endpoint for Wound Healing.
    Utsunomiya M; Takahara M; Iida O; Yamauchi Y; Kawasaki D; Yokoi Y; Soga Y; Ohura N; Nakamura M;
    JACC Cardiovasc Interv; 2017 Jan; 10(2):188-194. PubMed ID: 28104214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a new scoring system to predict wound healing after endovascular therapy in critical limb ischemia with tissue loss.
    Kobayashi N; Hirano K; Nakano M; Muramatsu T; Tsukahara R; Ito Y; Ishimori H; Yamawaki M; Araki M; Takimura H; Sakamoto Y
    J Endovasc Ther; 2015 Feb; 22(1):48-56. PubMed ID: 25775680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex relationship of body mass index with mortality in patients with critical limb ischemia undergoing endovascular treatment.
    Murata N; Soga Y; Iida O; Yamauchi Y; Hirano K; Kawasaki D; Fujihara M; Tomoi Y
    Eur J Vasc Endovasc Surg; 2015 Mar; 49(3):297-305. PubMed ID: 25524520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for adverse outcomes after endovascular therapy for critical limb ischemia with tissue loss due to infrainguinal artery disease.
    Tnishibe T; Yamamoto K; Toguchi K; Seike Y; Ito N; Nishibe M; Koizumi J; Dardik A; Ogino H
    Int Angiol; 2016 Oct; 35(5):477-83. PubMed ID: 26344514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interim Results of the PROMISE I Trial to Investigate the LimFlow System of Percutaneous Deep Vein Arterialization for the Treatment of Critical Limb Ischemia.
    Mustapha JA; Saab FA; Clair D; Schneider P
    J Invasive Cardiol; 2019 Mar; 31(3):57-63. PubMed ID: 30819976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of infection severity on clinical outcomes in critical limb ischemia with tissue loss after endovascular treatment.
    Makino K; Hirano K; Kobayashi N; Yamawaki M; Araki M; Sakamoto Y; Shinsuke M; Ito Y
    Heart Vessels; 2019 Jan; 34(1):84-94. PubMed ID: 29967952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of limb outcomes between bypass surgery and endovascular therapy in dialysis-dependent and -independent patients with chronic limb-threatening ischemia.
    Morisaki K; Guntani A; Matsuda D; Kinoshita G; Kawanami S; Yoshino S; Inoue K; Honma K; Yamaoka T; Mii S; Komori K; Yoshizumi T
    J Vasc Surg; 2024 Feb; 79(2):316-322.e2. PubMed ID: 37802402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of non-healing in patients with critical limb ischemia and tissue loss following successful endovascular therapy.
    Kobayashi N; Hirano K; Nakano M; Muramatsu T; Tsukahara R; Ito Y; Ishimori H; Yamawaki M; Araki M; Kato T
    Catheter Cardiovasc Interv; 2015 Apr; 85(5):850-8. PubMed ID: 25099930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of cilostazol after endovascular treatment for infrainguinal disease in patients with critical limb ischemia.
    Soga Y; Iida O; Hirano K; Suzuki K; Kawasaki D; Miyashita Y; Tsuchiya T; Nobuyoshi M
    J Vasc Surg; 2011 Dec; 54(6):1659-67. PubMed ID: 21872419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk stratification for low extremity amputation in critical limb ischemia patients who have undergone endovascular revascularization: A survival tree analysis.
    Huang HL; Juang JJ; Hsieh CA; Chou HH; Jang SJ; Ko YL
    Medicine (Baltimore); 2019 Aug; 98(33):e16809. PubMed ID: 31415395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of a multidisciplinary team approach in critical limb ischemia.
    Suzuki H; Maeda A; Maezawa H; Togo T; Nemoto H; Kasai Y; Ito Y; Nakada T; Sueki H; Mizukami A; Takayasu M; Iwaku K; Takeuchi S; Tanaka H; Iso Y
    Heart Vessels; 2017 Jan; 32(1):55-60. PubMed ID: 27106919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mid-Term Outcomes of Endovascular Treatment for TASC-II D Femoropopliteal Occlusive Disease with Critical Limb Ischemia.
    Torres-Blanco Á; Edo-Fleta G; Gómez-Palonés F; Molina-Nácher V; Ortiz-Monzón E
    Cardiovasc Intervent Radiol; 2016 Mar; 39(3):344-52. PubMed ID: 26202389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower extremity autologous vein bypass for critical limb ischemia is not adversely affected by prior endovascular procedure.
    Santo VJ; Dargon P; Azarbal AF; Liem TK; Mitchell EL; Landry GJ; Moneta GL
    J Vasc Surg; 2014 Jul; 60(1):129-35. PubMed ID: 24613692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.